Breast Cancer Clinical Trials in San Francisco

Showing 161-180 of 215 trials

Integrative Approaches For Cancer Survivorship 2: Project 1

NCT02897635

The purpose of this study is to develop and test a 12-month Integrative Medicine intervention based on Ayurvedic medicine in recent breast cancer survivors.

Breast Cancer

University of California, San Francisco20 participantsStarted Sep 2016

San Francisco, California, United States

COMPLETEDPHASE1/PHASE2< 1 mile

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

NCT02403271

This is a Phase 1b/2, multi-center study to assess the safety and efficacy of ibrutinib in combination with durvalumab (MEDI4736) in participants with relapsed or refractory solid tumors.

Non-Small Cell Lung CancerBreast CancerPancreatic Cancer

Pharmacyclics LLC.124 participantsStarted Mar 2015

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • La Jolla, California, United States +14 more locations

COMPLETED< 1 mile

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

NCT00755313

RATIONALE: Gathering information over time from laboratory tests, imaging scans, and assessment tests may help doctors learn more about the side effects of chemotherapy and plan the best treatment. PURPOSE: This clinical trial is studying the effects of chemotherapy on the brain in women with newly diagnosed early-stage breast cancer.

Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more

University of California, San Francisco81 participantsStarted May 2007

San Francisco, California, United States

Integrative Approaches For Cancer Survivorship 2: Project 1

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Breast Cancer Trials in Other Cities

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

Vitamin D and Breast Cancer: Does Weight Make a Difference?

Circadian Thermal Sensing to Detect Breast Disease

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

NOLAN: Naproxen or Loratadine and Neulasta

Digital Mammography Screening Trial (ACRIN6652)

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

Other Conditions in San Francisco